Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_assertion description "[Stable expression of K18Y-TATI in HT-29 5M21 cells downregulated tumor growth, angiogenesis and the expression of several metastasis-related genes, including CSPG4 (13.8-fold), BMP-7 (9.7-fold), the BMP antagonist CHORDIN (5.2-fold), IGFBP-2 and IGF2 (9.6- and 4.6-fold).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_assertion evidence source_evidence_literature NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_assertion SIO_000772 18317448 NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_assertion wasDerivedFrom befree-20140225 NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_assertion wasGeneratedBy ECO_0000203 NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.
- befree-20140225 importedOn "2014-02-25" NP382337.RA_FwrZ3vPbuynC8EsnaPnIBt3CKns-esUns52eYxkr8g130_provenance.